The primary purpose of this research study is to learn about how the level of a protein called p16 changes in the blood of children, adolescents, and adults with sickle cell disease. This protein can provide information about cellular aging which has not been studied before in patients with sickle cell disease. This can help develop future areas of research into sickle cell disease.

This study will test the effect and effectiveness of labels on political ads that disclose the use of generative AI. Governments and some internet platforms have begun requiring that political advertisers include these disclaimers, however we lack experimental study of the effect and effectiveness of these disclaimers.

This study will examine how, if at all, schools are using the school improvement process to identify and address inequities.

The purpose of this research study is to see how effective the use of copper Cu 64 PSMA I&T Injection is in imaging prostate cancer tumors for staging of men with newly diagnosed intermediate or high risk prostate cancer who are planned to have radical prostatectomy with pelvic lymph node dissection.

To determine whether newly-developed naloxone training materials increase how often pharmacists dispense naloxone.

To understand current pneumococcal vaccination practices and vaccination barriers at rural community pharmacies in the southeast.

To understand if advanced communication training for 4th year medical students improves comfort with having difficult conversations as resident physicians.

The goal of this project is to understand how community pharmacies work collaboratively with patients to reduce the harm that opioid misuse can cause. Investigators are also seeking to understand what challenges community pharmacies face when trying to decrease harm from opioids by supporting safe use of opioid medications and access to medications for opioid use disorder treatment and opioid overdose reversal. Information gathering efforts are being focused on community pharmacies that serve racial and ethnic minority communities in rural areas. Triangle CERSI scientists are working collaboratively with the FDA to survey and interview pharmacists, pharmacy technicians, patients, and other community members to collect and analyze data needed to better understand community pharmacy challenges in these areas. Ultimately, investigators seek to explore effective ways to reduce the harm from opioid misuse among underserved communities.

We want to test adults with sickle cell disease, using both the conventional in-person Montreal Cognitive Assessment (MOCA) and, within 2-4 months, the abbreviated 'MOCA-blind', which can be given remotely. In this way we can begin to evaluate whether these tests are sensitive to similar degrees of impairment when given remotely compared with in-person in people with sickle cell disease (SCD).